Shah Capital withdraws campaign against three Novavax directors

May 20 (Reuters) – Hedge fund Shah Capital said on Monday that it was withdrawing its preliminary proxy statement and its campaign against the re-election of three directors on Novavax’s board.

Shah Capital owns an about 7.8% stake in the COVID-19 vaccine maker, according to a regulatory filing on Monday. (Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar)

(c) Copyright Thomson Reuters 2024. Click For Restrictions – https://agency.reuters.com/en/copyright.html